Literature DB >> 8661759

Small bowel Procardia XL tablet bezoar mimicking cystic pneumatosis intestinalis.

H Y Kwon1, R L Scott, J P Mulloy.   

Abstract

Procardia XL Extended Release Tablets are being used with increasing frequency in the treatment of angina and hypertension. Bezoar formation, secondary to retained insoluble medication shells, is an important but less well-known complication. We report the first case of a small bowel bezoar due to this unique medication system.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8661759     DOI: 10.1007/s002619900029

Source DB:  PubMed          Journal:  Abdom Imaging        ISSN: 0942-8925


  3 in total

1.  Gastrointestinal safety of an extended-release, nondeformable, oral dosage form (OROS: a retrospective study.

Authors:  Dorsey M Bass; Mary Prevo; Deborah S Waxman
Journal:  Drug Saf       Date:  2002       Impact factor: 5.606

2.  Antihypertensive pharmacobezoar.

Authors:  L Michael Prisant; Vernon C Spaulding
Journal:  J Clin Hypertens (Greenwich)       Date:  2006-04       Impact factor: 3.738

3.  Venlafaxine pharmacobezoar causing intestinal ischemia requiring emergent hemicolectomy.

Authors:  Derrick Lung; Cristina Cuevas; Uwais Zaid; Benedict Ancock
Journal:  J Med Toxicol       Date:  2011-09
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.